Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Prevention & Management of Postpartum Hemorrhage

Obstet Gynecol; ePub 2017 Oct; ACOG

Obstetricians-gynecologists and other obstetric care providers can play key roles in implementing standardized bundles of care, such as policies, guidelines, and algorithms, for the management of postpartum hemorrhage, according to new clinical management guidelines from the American College of Obstetricians and Gynecologists (ACOG). The new practice bulletin discusses risk factors for postpartum hemorrhage as well as its evaluation, prevention, and management. Among the recommendations and conclusions:

Level A:

  • All obstetric care facilities should have guidelines for the routine administration of uterotonics in the immediate postpartum period.
  • Uterotonic agents should be the first-line treatment for postpartum hemorrhage caused by uterine atony. The specific agent selected, outside of recognized contraindications, is at the health care provider’s discretion because none has been shown to have greater efficacy than others for the treatment of uterine atony.

Level B:

  • When uterotonics fail to adequately control postpartum hemorrhage, prompt escalation to other interventions and escalation of intensity of care and support personnel are indicated.
  • Given the mortality reduction findings, tranexamic acid should be considered in the setting of obstetric hemorrhage when initial medical therapy fails.
  • Obstetrician–gynecologists and other obstetric care providers should work with their institutions to ensure the existence of a designated multidisciplinary response team, a staged postpartum hemorrhage protocol that includes guidelines for escalation of care, and a functioning massive transfusion protocol.


Postpartum hemorrhage. Practice Bulletin No. 183. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2017;130:e168–86.

This Week's Must Reads

Unintended Pregnancy & Interpregnancy Interval, Contraception; ePub 2018 Mar 1; Ahrens, et al

Do Meds Reduce Bleeding During Surgical Abortions?, Contraception; ePub 2018 Feb 25; Whitehouse, et al

Assessing Rate of POP Surgery in the US, Obstet Gynecol; 2018 Mar; Sammarco, et al

Opioid Administration After Pelvic Surgery, Female Pelvic Med Reconstr Surg; ePub 2018 Feb 27; Willis-Gray, et al

Is Group Prenatal Care a Viable Option?, Obstet Gynecol; ePub 2018 Mar; McCue, Borders, et al

Must Reads in Clinical Guidelines

Is Group Prenatal Care a Viable Option?, Obstet Gynecol; ePub 2018 Mar; McCue, Borders, et al

USPSTF: Screening for Ovarian Cancer, JAMA; 2018 Feb 13; USPSTF, Grossman, et al

ACOG Offers Guidance on Management of GDM, Obstet Gynecol; ePub 2018 Feb; ACOG, Turrentine

ACOG Recommendations: Fatigue and Patient Safety, Obstet Gynecol; ePub 2018 Feb; ACOG, Gregg

Social Determinants of Health in Reproductive Care, Obstet Gynecol; ePub 2018 Jan; ACOG, et al